Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Inizio

    Website
    Email
    +44 020 3861 3999

    Inizio is your market-leading commercialization partner.

    We provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Leveraging our connected suite of capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle, creating solutions that simplify the complex, unlock value, and enhance treatment outcomes.

    6th Floor, Holborn Gate, 26 Southampton Buildings, WC2A 1AN United Kingdom

    At the heart of our success are the talented experts who work hand-in-hand with our clients to deliver exceptional value, innovation, and impact. Explore our latest awards, achievements, and recognitions as we continue to set new standards and reimagine the future of health here.

     

    With >10,500 specialists across >50 countries, we unite global reach with deep, broad expertise in science, strategy, creativity, and technology. Our work spans all 14 therapeutic areas, and we’re proud to support every one of the top 20 pharmaceutical companies worldwide. What sets us apart is how we bring our capabilities together, across five areas of our business:

     

    Inizio Advisory

    Inizio Advisory partners with global life science and healthcare companies to create lasting change in human healthcare.

    Across four businesses in market research (Research Partnership), strategic consulting (Putnam), management consulting (Vynamic), and brand alignment (STEM), Inizio Advisory support clients at every stage of the product and patient journey, accelerating clinical and commercial success and long-term value.

     

    Inizio Medical

    Inizio Medical connects scientific expertise and technology to create compelling content and experiences that inform, inspire, and engage medical communities globally.

    Inizio Medical brings together three of the most recognized and trusted global medical communications agencies – ApotheCom, Ashfield MedComms and Nucleus Global –  underpinned with best-in-class Medical Affairs consulting, data analytics, integrated evidence generation, and industry-leading AI solutions through medical excellence and transformation agency, MEDiSTRAVA.

     

    Inizio Evoke

    Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insight and human centricity.

    Inizio Evoke – a full-service team of creative problem solvers who always find a way to make health more human™ – is built to design intuitive, people-centric experiences, brands, and businesses that drive transformative growth across brand and creative, communications, transformation, access, and media.

     

    Inizio Engage

    Inizio Engage is a global strategic, commercial, and creative engagement partner.

    Combining a unique mix of consultation, creation, and activation expertise with the latest technology, Inizio Engage design and deliver tailored solutions that inspire lasting change across decision optimization, experience design (XD), patient solutions, Medical Affairs, and commercial.

     

    Inizio Biotech

    Inizio Biotech develops personalized solutions curated to maxmise asset value at every opportunity.

    Providing best-in-class services across the clinical development and commercialization journey, our biotech solutions are highly personalized and coordinated through a single strategic point of contact. Inizio Biotech support you by guiding, validating, and inspiring the decisions that matter most.

    Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

    Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

    Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

    As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

    How DataGateway unified oncology data for real-world insights & market intelligence

    Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

    Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

    Preparing for ASH 2025: Pharma’s role in hematology innovation

    As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

    AI without limits: A smarter, integrated approach to Medical Affairs

    At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

    What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

    Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

    AI with intent: How Inizio is redefining pharma through precision and partnership

    At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

    Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

    Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

    ALL PRESS RELEASES

    Research conducted by Research Partnership published in leading medical journal

    Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

    Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist

    Hiding between the lines of any company’s ledgers is an intangible asset, invisible to most auditors, but with the potential to have a very real impact on bottom line. Pharma...

    Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

    Watch the webcast: http://bit.ly/2oTpzFjA shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories,...

    A researcher’s guide to Key Driver Analysis

    Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business

    Research Partnership sends a cheque for $10,000 to Forever Angels

    Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

    Pharma Market Research Conference, 2018

    We are delighted to be presenting and exhibiting at PMRC, 14-15 February in Newark, NJ.

    Out of the shadows: Mental health in the Asia Pacific region

    In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia

    Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

    Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative...

    Research Partnership has published a new patient Living with Psoriasis (EU) report

    Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU)....

    New opportunities in emerging markets

    Published in Pharma Exec January 2018 by Rachel Howard

    ALL WHITE PAPERS

    Reimagine health with Inizio.

    At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

    PEGASUS SHOWREEL 2017

    What we do and who we do it for | Pegasus

    We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

    Understanding decision making in health | Pegasus

    To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

    An animated approach to communicating healthy messages | Pegasus

    Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

    ALL VIDEOS AND PODCASTS

    At Inizio, sustainability means minimizing our environmental impact, championing inclusion, promoting health equity, and operating in a responsible, ethical manner that allows us to grow in a way that benefits all our stakeholders.

    Guided by our Commitments, our people are empowered to make a real difference. In our latest report, we’re proud to present the significant progress we made in 2024. Read our 2024 Sustainability Report. 

    Ryan Quigley

    Ryan Quigley
    CEO, Inizio

    Gavin McShera

    Gavin McShera
    Chief Information Officer, Inizio

    Mary-Kate McGarry

    Mary-Kate McGarry
    Chief Strategy & Innovation Officer, Inizio

    Ben Jackson

    Ben Jackson
    CFO, Inizio

    Colin Stanley

    Colin Stanley
    CCO, Inizio

    Grainne McAleese

    Grainne McAleese
    Deputy CFO, Inizio

    Stephanie Hasenbos-Case

    Stephanie Hasenbos-Case
    Chief Human Resources Officer, Inizio

    Remco op den Kelder

    Remco op den Kelder
    President, Inizio Advisory

    Elaine Ferguson

    Elaine Ferguson
    Global President, Inizio Medical

    Reid Connolly

    Reid Connolly
    Global President, Inizio Evoke

    Jim Sage

    Jim Sage
    Global President, Inizio Engage

    Company Details

    - PMLiVE

    Email
    Website

     Latest Content from  Inizio 

    Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

    Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

    Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

    As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

    How DataGateway unified oncology data for real-world insights & market intelligence

    Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

    Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

    Preparing for ASH 2025: Pharma’s role in hematology innovation

    As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

    AI without limits: A smarter, integrated approach to Medical Affairs

    At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

    What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

    Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

    AI with intent: How Inizio is redefining pharma through precision and partnership

    At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

    Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

    Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.